Debt to Equity Ratio Chart

View Debt to Equity Ratio for KAOOY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 0.2119
March 31, 2026 0.2246
December 31, 2025 0.2285
September 30, 2025 0.2309
June 30, 2025 0.2285
March 31, 2025 0.2393
December 31, 2024 0.23
September 30, 2024 0.2528
June 30, 2024 0.2452
March 31, 2024 0.2728
December 31, 2023 0.2654
September 30, 2023 0.2693
June 30, 2023 0.2651
March 31, 2023 0.2682
December 31, 2022 0.2704
September 30, 2022 0.2636
June 30, 2022 0.2639
March 31, 2022 0.2717
December 31, 2021 0.2784
September 30, 2021 0.2899
June 30, 2021 0.2908
March 31, 2021 0.2975
December 31, 2020 0.2969
September 30, 2020 0.3143
June 30, 2020 0.2889
Date Value
March 31, 2020 0.3318
December 31, 2019 0.3361
September 30, 2019 0.3521
June 30, 2019 0.3528
March 31, 2019 0.3478
December 31, 2018 0.1499
September 30, 2018 0.1516
June 30, 2018 0.1545
March 31, 2018 0.1521
December 31, 2017 0.1535
September 30, 2017 0.1652
June 30, 2017 0.1695
March 31, 2017 0.1787
December 31, 2016 0.1833
September 30, 2016 0.1859
June 30, 2016 0.1802
March 31, 2016 0.181
December 31, 2015 0.2083
September 30, 2015 0.1869
June 30, 2015 0.1866
March 31, 2015 0.1959
December 31, 2014 0.1839
September 30, 2014 0.1663
June 30, 2014 0.159
March 31, 2014 0.16

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Kosé Holdings Corp. 0.0379
euglena Co., Ltd. 0.695
Milbon Co., Ltd. 0.00
Rohto Pharmaceutical Co., Ltd. 0.1877
Mandom Corp. 0.0485